Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1's low clinical toxicity
| Image |  |
|---|---|
| Description | scientific article published on 18 October 2019 |
| Author/s |
author: Qiang Chen |
| Publication date | October 18, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |